New combination therapy launched to treat womb cancer

Women with advanced womb cancer in the UK are to be offered a new combination therapy which could extend life expectancy for twice as long as chemotherapy.  The drugs, pembrolizumab and lenvatinib, work together to slow the progression of the cancer, adding up to seven months onto patients’ lives.  The new treatment was approved for …

Continue reading "New combination therapy launched to treat womb cancer"